TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate/Gαs signaling.
about
Cholangiocyte autophagy contributes to hepatic cystogenesis in polycystic liver disease and represents a potential therapeutic target.The combination of an HDAC6 inhibitor and a somatostatin receptor agonist synergistically reduces hepato-renal cystogenesis in an animal model of polycystic liver disease.Biliary epithelium: A neuroendocrine compartment in cholestatic liver disease
P2860
TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate/Gαs signaling.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
TGR5 contributes to hepatic cy ...... e monophosphate/Gαs signaling.
@en
type
label
TGR5 contributes to hepatic cy ...... e monophosphate/Gαs signaling.
@en
prefLabel
TGR5 contributes to hepatic cy ...... e monophosphate/Gαs signaling.
@en
P2093
P2860
P356
P1433
P1476
TGR5 contributes to hepatic cy ...... e monophosphate/Gαs signaling.
@en
P2093
Anatoliy I Masyuk
Bing Q Huang
Brynn N Howard
Eduard Sergienko
Maria Lorenzo Pisarello
Nicholas F LaRusso
Robert J Ardecky
Tatyana V Masyuk
Thomas D Y Chung
Xavier Fung
P2860
P304
P356
10.1002/HEP.29284
P407
P577
2017-05-23T00:00:00Z